KKR to buy Envision for $5.57 bln

KKR to buy Envision for $5.57 bln

Finally, M&T Bank Corp boosted its position in shares of Envision Healthcare by 33.6% during the fourth quarter.

If KKR completes the deal, Envision will become a private company, and its shares will no longer trade on the New York Stock Exchange. Envision said the $46-a-share price represents a 32% premium to its stock price in November, when it announced it was reviewing strategic alternatives. After $0.65 actual earnings per share reported by Envision Healthcare Corporation for the previous quarter, Wall Street now forecasts 23.08 % EPS growth. Zeke Capital Advisors LLC bought a new position in shares of Envision Healthcare during the first quarter worth $229,000. Silchester International Investors LLP's holdings in Envision Healthcare were worth $2,254,000 as of its most recent SEC filing. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company's stock valued at $221,000 after buying an additional 3,000 shares during the period. Institutional investors own 35.96% of the company's stock.

Private equity firm KKR & Co. will buy Envision Healthcare Corp. for $5.57 billion plus debt, after a lengthy sale process by the hospital staffing and surgical center company.

Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings data on Tuesday, May 2nd. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The company had revenue of $2.08 billion for the quarter, compared to analyst estimates of $2.02 billion.

Several research firms have weighed in on EVHC.

Investors sold shares of Envision Healthcare (NYSE:EVHC) on strength during trading on Monday. Cantor Fitzgerald maintained Envision Healthcare Corporation (NYSE:EVHC) on Friday, January 5 with "Hold" rating. The stock has "Buy" rating by Robert W. Baird on Wednesday, March 7. Canaccord Genuity increased their target price on shares of Envision Healthcare from $46.00 to $48.00 and gave the company a "buy" rating in a research report on Wednesday, May 9th. The firm has "Hold" rating by Cantor Fitzgerald given on Wednesday, February 21. $43.46's average target is -2.67% below currents $44.65 stock price. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/envision-healthcare-corporation-nyse-evhc/, or calling toll free 877-LEGAL-90. The stock was sold at an average price of $65.00, for a total value of $97,500.00.

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company.

Envision Healthcare Corporation (NYSE:EVHC) has declined 22.24% since June 12, 2017 and is downtrending. The firm operates through three reportable divisions: Physician Services, Medical Transportation, and Ambulatory Services. Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Related Articles